摘要
目的观察经鼻高流量氧疗(HFNC)治疗急性I型呼吸衰竭患者的临床疗效。方法 63例急性I型呼吸衰竭患者随机分为HFNC组(32例)、无创正压通气(NPPV)组(31例),比较两组治疗效果及不良反应。结果 HFNC组患者治疗2、8、24、48 h后呼吸频率、心率低于NPPV组,且疼痛评分及腹胀发生率低于NPPV组(P<0.05)。结论 HFNC在改善氧合、呼吸作功方面与NPPV等效,但可有效降低面部疼痛及腹胀发生率。
Objective To observe the clinical efficacy of high flow nasal cannula(HFNC)oxygen therapy in acute type Ⅰ respiratory failure(ARF1).Methods Sixty-three patients with ARF1 were randomized to HFNC(n=32)and non-invasive positive pressure ventilation(NPPV,n=31)groups.The curative effect and adverse reactions were compared between two groups.Results The 2-h,8-h,24-h,and 48-h respiratory and heart rates,pain score and abdominal distension were lower in HFNC group than in NPPV group(P<0.05).Conclusion HFNC is comparable to NIPPV in improving the oxygenation and respiratory working,but can significantly reduce the facial pain and abdominal distension.
作者
罗裕锋
叶晖
王石林
瞿嵘
凌云
LUO Yu-feng;YE Hui;WANG Shi-lin;QU Rong;LING Yun(Department of Intensive Care Unit,Huizhou Central People’s Hospital,Huizhou 516001,China)
出处
《广东医科大学学报》
2018年第6期690-692,共3页
Journal of Guangdong Medical University
基金
广东省惠州市科技计划项目(No.2017Y027)
关键词
经鼻高流量氧疗
急性Ⅰ型呼吸衰竭
无创正压通气
high-flow nasal cannula oxygen therapy
acute type Ⅰ respiratory failure
noninvasive positive pressure ventilation
